The Huntington’s Disease Society of America is the premier not-for-profit organization dedicated to improving the lives of everyone affected by Huntington’s disease.
From community services and education to advocacy and research, HDSA is the world’s leader in providing help for today, hope for tomorrow for people with Huntington’s disease and their family.
Location: United States, New York
Employees: 11-50
Total raised: $208K
Founded date: 1967
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.10.2022 | - | $208K | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 14.02.2024 | I was 16 when I found out I might have a terminal disease. I... | Health I was 16 when I found out I might have a terminal disease. I waited a decade to get tested, b... | businessin... |
| 26.08.2022 | No Myth: CEO of ADC upstart calls it quits; Bristol Myers... | The 50-year race to develop an RSV vaccine turned a corner on Thursday with Pfizer unveiling promisi... | endpts.com... |
| 26.08.2022 | No Myth: CEO of ADC upstart calls it quits; Bristol Myers... | CAR-T therapies traditionally have been made using virus vectors, such as lentivirus or γ-retrovirus... | endpts.com... |
| 26.08.2022 | No Myth: CEO of ADC upstart calls it quits; Bristol Myers... | Novartis has suspended dosing in a Huntington’s disease study after safety signals emerged that poin... | endpts.com... |
| 26.08.2022 | No Myth: CEO of ADC upstart calls it quits; Bristol Myers... | Novartis CEO Vas Narasimhan has finally figured out how he can get Sandoz off his list of major head... | endpts.com... |
| 26.08.2022 | No Myth: CEO of ADC upstart calls it quits; Bristol Myers... | Alex Nichols → When Mythic Therapeutics CEO Alex Nichols spoke to Endpoints News last Decembe... | endpts.com... |
| 25.08.2022 | French penny stock will no longer knock on FDA door for ap... | Things are not looking up for the French biotech Erytech Pharma. The company is knocking off i... | endpts.com... |
| 25.08.2022 | J&J and AbbVie's blockbuster BTK inhibitor scoops a ... | As J&J and AbbVie duke it out with AstraZeneca and other BTK competitors in chronic lymp... | endpts.com... |
| 25.08.2022 | Armed with $100M grant, ElevateBio looks to create biom... | While Pittsburgh has a rich manufacturing history, one biotech is looking to make the city m... | endpts.com... |
| 29.12.2021 | Поломки в дофаминовой системе | Нейромедиатор, связанный с вниманием и двигательной активностью Дофамин наиболее известен как «гормо... | habr.com/r... |
Show more